News

Shares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug ...
Rocket Pharmaceuticals RCKT announced that the FDA has cleared its investigational new drug (IND) application seeking to begin clinical studies on its first-in-class gene therapy candidate, RP-A701.
and premature mortality Rocket plans to conduct a Phase 1 trial in the U.S. and is working towards the first patient treatment "The FDA clearance of RP-A701, our third clinical-stage gene therapy ...
Investing.com -- Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock rose 2.4% after the company announced it received clearance from the U.S. Food and Drug Administration for its Investigational New Drug ...
Shares in Rocket Pharmaceuticals have been living up to their name, shooting up following encouraging early-stage clinical trial results from a gene therapy for a serious inherited rare heart disease.
Scientists have long sought to understand why sea spiders keep some of their most important organs in their legs.
Scientists at Empa have discovered how scaly-tailed squirrels grip trees, paving the way for agile, energy-efficient bionic robots and drones.
The U.S. FDA has cleared Rocket Pharmaceuticals Inc.’s IND application for RP-A701, an AAVrh.74-based gene therapy candidate for the treatment of BAG3-associated dilated cardiomyopathy (BAG3-DCM), a ...
Virtual power plants turn distributed energy assets like EVs and solar into grid resources without new infrastructure.
The 6th Gene Therapy Analytical Development Summit Europe, taking place from 20 th – 22 nd May 2025 in London, returns as the only European forum solely dedicated to tackling th ...